We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+2.26%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$3.43B
AUM Growth
-$3.53B
Cap. Flow
-$6.14B
Cap. Flow %
-178.75%
Top 10 Hldgs %
20.05%
Holding
4,637
New
1,031
Increased
432
Reduced
2,408
Closed
565

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Financials 5.08%
3 Healthcare 4.17%
4 Consumer Discretionary 3.04%
5 Industrials 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VXX icon
3151
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$152M
$2.65K ﹤0.01%
+100
New +$3.27K
DAPP icon
3152
VanEck Digital Transformation ETF
DAPP
$238M
$2.65K ﹤0.01%
+160
New +$3.33K
AAT
3153
American Assets Trust
AAT
$1.45B
$2.63K ﹤0.01%
139
-13,261
-99% -$256K
CLSK icon
3154
CleanSpark
CLSK
$3.53B
$2.62K ﹤0.01%
259
-19
-7% -$285
THRM icon
3155
Gentherm
THRM
$1.25B
$2.62K ﹤0.01%
72
-3,385
-98% -$122K
ARQ icon
3156
Arq
ARQ
$84.6M
$2.62K ﹤0.01%
800
+586
+274% +$2.86K
IDT icon
3157
IDT Corp
IDT
$1.64B
$2.61K ﹤0.01%
51
-373
-88% -$18.7K
TBCH
3158
Turtle Beach Corp
TBCH
$243M
$2.61K ﹤0.01%
11,735
+5,715
+95% +$85K
AAXJ icon
3159
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.7B
$2.61K ﹤0.01%
+28
New +$2.6K
FSBW icon
3160
FS Bancorp
FSBW
$319M
$2.59K ﹤0.01%
63
-369
-85% -$14.8K
IMVT icon
3161
Immunovant
IMVT
$7.93B
$2.59K ﹤0.01%
102
-56
-35% -$1.25K
TRVI icon
3162
Trevi Therapeutics
TRVI
$2.59B
$2.58K ﹤0.01%
206
+21
+11% +$243
MLKN icon
3163
MillerKnoll
MLKN
$1.53B
$2.58K ﹤0.01%
141
-895
-86% -$14.6K
MOV icon
3164
Movado Group
MOV
$849M
$2.58K ﹤0.01%
125
-2,352
-95% -$45.9K
MEI icon
3165
Methode Electronics
MEI
$496M
$2.57K ﹤0.01%
387
-39,648
-99% -$281K
BCO icon
3166
Brink's
BCO
$4.88B
$2.57K ﹤0.01%
22
-497
-96% -$56.8K
RDNT icon
3167
RadNet
RDNT
$5.02B
$2.57K ﹤0.01%
36
-271
-88% -$20.9K
PCH
3168
DELISTED
PotlatchDeltic
PCH
$2.56K ﹤0.01%
64
-5,363
-99% -$217K
LXU icon
3169
LSB Industries
LXU
$783M
$2.56K ﹤0.01%
301
-1,247
-81% -$11K
MPT
3170
Medical Properties Trust
MPT
$2.77B
$2.56K ﹤0.01%
511
-157,580
-100% -$820K
SEG
3171
Seaport Entertainment Group
SEG
$336M
$2.55K ﹤0.01%
129
-360
-74% -$8.07K
CAI
3172
Caris Life Sciences
CAI
$4.43B
$2.54K ﹤0.01%
94
-123
-57% -$3.46K
CIM
3173
Chimera Investment
CIM
$1.04B
$2.54K ﹤0.01%
204
-7,132
-97% -$90.6K
KBWB icon
3174
Invesco KBW Bank ETF
KBWB
$6.83B
$2.53K ﹤0.01%
+30
New +$2.37K
SIBN icon
3175
SI-BONE Inc
SIBN
$788M
$2.52K ﹤0.01%
128
-856
-87% -$14.9K

Similar funds

Arax Advisory Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Arax Advisory Partners held 4,637 positions worth $3.43B, down 51% from $6.97B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arax Advisory Partners withdrew a net $6.14B in Q4 2025, closing 565 positions and reducing 2,408 holdings. Its most notable exit was State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF, an estimated $39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Arax Advisory Partners opened a new position in Vanguard Morningstar Growth ETF worth $122M.

  • Arax Advisory Partners's largest Q4 2025 buy was Vanguard Morningstar Growth ETF: 1,504,890 shares worth $122M.
  • Arax Advisory Partners added most to Vanguard Total International Stock ETF in Q4 2025, an estimated $13M increase.
  • Arax Advisory Partners's biggest Q4 2025 reduction was iShares S&P 100 ETF, cutting an estimated $2.6B.
  • Arax Advisory Partners fully exited State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF in Q4 2025, selling an estimated $39M.
  • Arax Advisory Partners's ten largest holdings make up 20% of its $3.43B portfolio in Q4 2025.
  • Arax Advisory Partners opened 1,031 new positions and closed 565 in Q4 2025.
  • Arax Advisory Partners's portfolio value fell 51% quarter-over-quarter to $3.43B.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.